Guidelines on the Clinical Evaluation of Medicinal Products for Treatment of Dyslipidemia

Shizuya Yamashita; Daisaku Masuda; Masahiro Akishita; Hidenori Arai; Yujiro Asada; Kazushige Dobashi; Kensuke Egashira; Mariko Harada-Shiba; Kenichi Hirata; Shun Ishibashi; Kouji Kajinami; Makoto Kinoshita; Koichi Kozaki; Masafumi Kuzuya; Masatsune Ogura; Tomonori Okamura; Kayoko Sato; Hitoshi Shimano; Kazuhisa Tsukamoto; Masayuki Yokode; Koutaro Yokote; Masayuki Yoshida

doi:10.5551/jat.CR004

Guidelines on the Clinical Evaluation of Medicinal Products for Treatment of Dyslipidemia

J Atheroscler Thromb. 2020 Nov 1;27(11):1246-1254. doi: 10.5551/jat.CR004. Epub 2020 Aug 28.

Authors

Shizuya Yamashita¹, Daisaku Masuda¹, Masahiro Akishita², Hidenori Arai³, Yujiro Asada⁴, Kazushige Dobashi⁵, Kensuke Egashira⁶, Mariko Harada-Shiba⁷, Kenichi Hirata⁸, Shun Ishibashi⁹, Kouji Kajinami¹⁰, Makoto Kinoshita¹¹, Koichi Kozaki¹², Masafumi Kuzuya¹³, Masatsune Ogura¹⁴, Tomonori Okamura¹⁵, Kayoko Sato¹⁶, Hitoshi Shimano¹⁷, Kazuhisa Tsukamoto¹⁸, Masayuki Yokode¹⁹, Koutaro Yokote²⁰, Masayuki Yoshida²¹

Affiliations

¹ Rinku General Medical Center.
² Department of Geriatric Medicine, Graduate School of Medicine, the University of Tokyo.
³ National Center for Geriatrics and Gerontology.
⁴ Department of Pathology, Faculty of Medicine, University of Miyazaki.
⁵ Department of Pediatrics, Enzan Citizen Hospital.
⁶ Department of Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences.
⁷ Department of Molecular Pathogenesis, National Cerebral and Cardiovascular Center Research Institute.
⁸ Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine.
⁹ Division of Endocrinology and Metabolism, Department of Medicine, Jichi Medical University.
¹⁰ Department of Cardiology, Kanazawa Medical University.
¹¹ Toray Industries, Inc.
¹² Department of Geriatric Medicine, Kyorin University School of Medicine.
¹³ Department of Community Healthcare and Geriatrics, Nagoya University Graduate School of Medicine.
¹⁴ Department of Molecular Innovation in Lipidology, National Cerebral and Cardiovascular Center Research Institute.
¹⁵ Preventive Medicine and Public Health, Keio University School of Medicine.
¹⁶ Department of Cardiology, Tokyo Women's Medical University.
¹⁷ Department of Internal Medicine (Endocrinology and Metabolism), Faculty of Medicine, University of Tsukuba.
¹⁸ Department of Internal Medicine, Teikyo University School of Medicine.
¹⁹ Department of Clinical Innovative Medicine, Kyoto University Graduate School of Medicine.
²⁰ Department of Endocrinology, Hematology and Gerontology, Chiba University Graduate School of Medicin.
²¹ Division of Medical Genetics, Medical Hospital of Tokyo Medical and Dental University.

No abstract available

Keywords: Clinical Evaluation; Guidelines; Japanese; LDL-C; Medicinal Products; Treatment of Dyslipidemia.

Publication types

Guideline

MeSH terms

Aged
Anticholesteremic Agents / pharmacology
Cardiology / standards*
Child
Cholesterol, LDL / blood
Clinical Trials as Topic
Drug Evaluation, Preclinical*
Dyslipidemias / drug therapy*
Dyslipidemias / therapy*
Female
Humans
Japan
Male
Risk Factors
Triglycerides / blood

Substances

Anticholesteremic Agents
Cholesterol, LDL
Triglycerides